Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Meetings
Meetings
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Societies Join Forces to Host Seventh European Lung Cancer Conference
lungcanc
4th AACR-IASLC International Joint Conference: Lung Cancer Translational Science from the Bench to the Clinic
IASLC 2019 World Conference on Lung Cancer: Collaborative Formats, Novel Data
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
EGFR-Targeted Therapy: A New Beginning
IASLC and ESMO Present 6th European Lung Cancer Conference
lungcanc
2017 Lung Cancer SPORE Workshop
lungcanc
IASLC 2019 Mesothelioma Meeting Offers Innovative Approach for Rapid Learning
lungcanc
Best of IASLC WCLC 2016
lungcanc
Lung Cancer Research Highlights from the 2019 ASCO Annual Meeting
lungcanc
IASLC Workshop in Lung Cancer Clinical Research
lungcanc
Studies Indicate Expanding Benefit of Checkpoint Inhibitors
lungcanc
Targeted Therapies Meeting Focuses on Upcoming Research Advances in Lung Cancer
lungcanc
7th IASLC Latin American Conference on Lung Cancer
lungcanc
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
lungcanc
1
2
3
...
6
Page 1 of 6
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS